Teladoc Health PE Ratio 2014-2023 | TDOC
Current and historical p/e ratio for Teladoc Health (TDOC) from 2014 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Teladoc Health PE ratio as of April 23, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Teladoc Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-23 | 13.74 | 0.00 | |
| 2023-12-31 | 21.55 | $-1.34 | 0.00 |
| 2023-09-30 | 18.59 | $-24.66 | 0.00 |
| 2023-06-30 | 25.32 | $-24.76 | 0.00 |
| 2023-03-31 | 25.90 | $-43.58 | 0.00 |
| 2022-12-31 | 23.65 | $-84.74 | 0.00 |
| 2022-09-30 | 25.35 | $-61.32 | 0.00 |
| 2022-06-30 | 33.21 | $-61.40 | 0.00 |
| 2022-03-31 | 72.13 | $-43.04 | 0.00 |
| 2021-12-31 | 91.82 | $-2.77 | 0.00 |
| 2021-09-30 | 126.81 | $-5.77 | 0.00 |
| 2021-06-30 | 166.29 | $-5.67 | 0.00 |
| 2021-03-31 | 181.75 | $-5.15 | 0.00 |
| 2020-12-31 | 199.96 | $-4.24 | 0.00 |
| 2020-09-30 | 219.24 | $-1.43 | 0.00 |
| 2020-06-30 | 190.84 | $-1.28 | 0.00 |
| 2020-03-31 | 155.01 | $-1.35 | 0.00 |
| 2019-12-31 | 83.72 | $-1.38 | 0.00 |
| 2019-09-30 | 67.72 | $-1.47 | 0.00 |
| 2019-06-30 | 66.41 | $-1.53 | 0.00 |
| 2019-03-31 | 55.60 | $-1.52 | 0.00 |
| 2018-12-31 | 49.57 | $-1.48 | 0.00 |
| 2018-09-30 | 86.35 | $-1.89 | 0.00 |
| 2018-06-30 | 58.05 | $-2.10 | 0.00 |
| 2018-03-31 | 40.30 | $-1.98 | 0.00 |
| 2017-12-31 | 34.85 | $-1.89 | 0.00 |
| 2017-09-30 | 33.15 | $-1.44 | 0.00 |
| 2017-06-30 | 34.70 | $-1.54 | 0.00 |
| 2017-03-31 | 25.00 | $-1.64 | 0.00 |
| 2016-12-31 | 16.50 | $-1.74 | 0.00 |
| 2016-09-30 | 18.31 | $-1.82 | 0.00 |
| 2016-06-30 | 16.02 | $-1.52 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.252B | $2.602B |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.697B | 15.52 |
| Cencora (COR) | United States | $47.247B | 18.86 |
| ICON (ICLR) | Ireland | $24.578B | 24.24 |
| DiDi Global (DIDIY) | China | $22.930B | 0.00 |
| Avantor (AVTR) | United States | $16.557B | 22.81 |
| CochLear (CHEOY) | $13.675B | 0.00 | |
| Viatris (VTRS) | United States | $13.496B | 3.85 |
| Revvity (RVTY) | United States | $12.448B | 21.67 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.029B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 21.84 |
| Medpace Holdings (MEDP) | United States | $11.658B | 38.35 |
| Solventum (SOLV) | United States | $10.708B | 0.00 |
| Natera (NTRA) | United States | $10.700B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.966B | 52.04 |
| Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
| Doximity (DOCS) | United States | $4.625B | 34.43 |
| Organon (OGN) | United States | $4.601B | 4.46 |
| PACS (PACS) | United States | $3.460B | 0.00 |
| Progyny (PGNY) | United States | $3.177B | 53.32 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| Surgery Partners (SGRY) | United States | $3.044B | 28.28 |
| Life Times (LTH) | United States | $2.774B | 30.65 |
| GoodRx Holdings (GDRX) | United States | $2.631B | 133.20 |
| Premier (PINC) | United States | $2.522B | 9.23 |
| AMN Healthcare Services Inc (AMN) | United States | $2.141B | 6.93 |
| Agilon Health (AGL) | United States | $2.121B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.816B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| Establishment Labs Holdings (ESTA) | $1.325B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.273B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.947B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
| Embecta (EMBC) | United States | $0.617B | 4.08 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.518B | 0.00 |
| Enhabit (EHAB) | United States | $0.515B | 46.64 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 0.00 |
| CareDx (CDNA) | United States | $0.423B | 0.00 |
| LifeMD (LFMD) | United States | $0.404B | 0.00 |
| Beauty Health (SKIN) | United States | $0.404B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.395B | 0.00 |
| DocGo (DCGO) | United States | $0.366B | 58.50 |
| MultiPlan (MPLN) | United States | $0.356B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.312B | 4.14 |
| GeneDx Holdings (WGS) | United States | $0.271B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
| Sharecare (SHCR) | United States | $0.250B | 0.00 |
| So-Young (SY) | China | $0.131B | 44.00 |
| Biodesix (BDSX) | United States | $0.125B | 0.00 |
| Oncology Institute (TOI) | United States | $0.084B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |